Concepedia

Publication | Open Access

1,25‐dihydroxyvitamin D<sub>3</sub> and PI3K/AKT inhibitors synergistically inhibit growth and induce senescence in prostate cancer cells

DOIFull Paper Access

47

Citations

48

References

2010

Year

Linara S. Axanova, Yong Q. Chen, Thomas P. McCoy, Guangchao Sui, Scott D. Cramer
The Prostate

Abstract

These findings provide the rationale for the development of therapies utilizing 1,25(OH)(2)D(3) or its analogs combined with inhibition of PI3K/AKT for the treatment of prostate cancer.

References

YearCitations

Page 1